Added to YB: 2026-01-07
Pitch date: 2026-01-05
BMRN [bullish]
BioMarin Pharmaceutical Inc.
+4.14%
current return
Author Info
Tensor Trader is a quantamental investor who combines value, quality, and momentum factor models with fundamental catalysts and a top-down macro view, turning messy data into clear signals. Sign up for the newsletter.
Company Info
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
Market Cap
$11.4B
Pitch Price
$58.87
Price Target
86.00 (+43%)
Dividend
N/A
EV/EBITDA
13.05
P/E
22.18
EV/Sales
3.41
Sector
Biotechnology
Category
growth
BioMarin Pharmaceutical (BMRN): An Asymmetric Opportunity at $59
BMRN: BUY, $86 price target (45% upside). $4.8B Amicus acquisition (Q2 2026) adds $600M revenue, ~$150M synergies. Voxzogo growth engine targeting $2B peak sales by 2034. 15% revenue CAGR, 40% operating margin target by 2026. Trades 12x EV/EBIT vs peers at premium. Risks: integration, competition.
Read full article (3 min)